DrugDashboards

Lamotrigine

Lamotirigine · LAMOTRIGINE 300 mg/1 · Tablet, Extended Release · Oral · Zydus Lifesciences Limited

NDC 70771-1519-03 · 30 TABLET, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA207763
TE code
AB
Approval date
Apr 1, 2020
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Lamotirigine (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
Zydus Lifesciences LimitedLAMOTRIGINE 100 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedLAMOTRIGINE 200 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedLAMOTRIGINE 25 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedLAMOTRIGINE 250 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedLAMOTRIGINE 300 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedLAMOTRIGINE 50 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lamotrigine — NDC 70771-1519-03," retrieved September 3, 2026, https://drugdashboards.com/drug/70771151903.

Free to cite with attribution — see how the data is put together.